Exact Mass: 610.2916914

Endomorphin-1

C34H38N6O5 (610.2903537999999)

Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. [HMDB] Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4]. Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4].

Blepharocalyxin C

C38H42O7 (610.2930382)

Atractyloside A 14-O-beta-D-fructofuranoside

C27H46O15 (610.2836566)

Areptin A

C31H46O12 (610.2989116)

A diterpenoid isolated from the aerial parts of Ajuga reptans.

Segetalin H

C29H38N8O7 (610.2863318)

Acarbethosid

C31H46O12 (610.2989116)

C31H46O12

C31H46O12 (610.2989116)

3,4-didesulphatedcarboxyatractyloside

C31H46O12 (610.2989116)

Phe Lys Met Trp

C31H42N6O5S (610.2937242)

Phe Lys Trp Met

C31H42N6O5S (610.2937242)

Phe Met Lys Trp

C31H42N6O5S (610.2937242)

Phe Met Trp Lys

C31H42N6O5S (610.2937242)

Phe Trp Lys Met

C31H42N6O5S (610.2937242)

Phe Trp Met Lys

C31H42N6O5S (610.2937242)

Lys Phe Met Trp

C31H42N6O5S (610.2937242)

Lys Phe Trp Met

C31H42N6O5S (610.2937242)

Lys Met Phe Trp

C31H42N6O5S (610.2937242)

Lys Met Trp Phe

C31H42N6O5S (610.2937242)

Lys Trp Phe Met

C31H42N6O5S (610.2937242)

Lys Trp Met Phe

C31H42N6O5S (610.2937242)

Met Phe Lys Trp

C31H42N6O5S (610.2937242)

Met Phe Trp Lys

C31H42N6O5S (610.2937242)

Met Lys Phe Trp

C31H42N6O5S (610.2937242)

Met Lys Trp Phe

C31H42N6O5S (610.2937242)

Met Trp Phe Lys

C31H42N6O5S (610.2937242)

Met Trp Lys Phe

C31H42N6O5S (610.2937242)

Arg Ser Trp Tyr

C29H38N8O7 (610.2863318)

Arg Ser Tyr Trp

C29H38N8O7 (610.2863318)

Arg Trp Ser Tyr

C29H38N8O7 (610.2863318)

Arg Trp Tyr Ser

C29H38N8O7 (610.2863318)

Arg Tyr Ser Trp

C29H38N8O7 (610.2863318)

Arg Tyr Trp Ser

C29H38N8O7 (610.2863318)

Ser Arg Trp Tyr

C29H38N8O7 (610.2863318)

Ser Arg Tyr Trp

C29H38N8O7 (610.2863318)

Ser Trp Arg Tyr

C29H38N8O7 (610.2863318)

Ser Trp Tyr Arg

C29H38N8O7 (610.2863318)

Ser Tyr Arg Trp

C29H38N8O7 (610.2863318)

Ser Tyr Trp Arg

C29H38N8O7 (610.2863318)

Trp Phe Lys Met

C31H42N6O5S (610.2937242)

Trp Phe Met Lys

C31H42N6O5S (610.2937242)

Trp Lys Phe Met

C31H42N6O5S (610.2937242)

Trp Lys Met Phe

C31H42N6O5S (610.2937242)

Trp Met Phe Lys

C31H42N6O5S (610.2937242)

Trp Met Lys Phe

C31H42N6O5S (610.2937242)

Trp Arg Ser Tyr

C29H38N8O7 (610.2863318)

Trp Arg Tyr Ser

C29H38N8O7 (610.2863318)

Trp Ser Arg Tyr

C29H38N8O7 (610.2863318)

Trp Ser Tyr Arg

C29H38N8O7 (610.2863318)

Trp Tyr Arg Ser

C29H38N8O7 (610.2863318)

Trp Tyr Ser Arg

C29H38N8O7 (610.2863318)

Tyr Arg Ser Trp

C29H38N8O7 (610.2863318)

Tyr Arg Trp Ser

C29H38N8O7 (610.2863318)

Tyr Ser Arg Trp

C29H38N8O7 (610.2863318)

Tyr Ser Trp Arg

C29H38N8O7 (610.2863318)

Tyr Trp Arg Ser

C29H38N8O7 (610.2863318)

Tyr Trp Ser Arg

C29H38N8O7 (610.2863318)

Endomorphin-1

C34H38N6O5 (610.2903537999999)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4]. Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4].

1,3-BIS(BIS((1H-BENZO[D]IMIDAZOL-2-YL)METHYL)AMINO)PROPAN-2-OL

C35H34N10O (610.2916914)

Fmoc-HomoArg(Boc)2-OH

C32H42N4O8 (610.3002492)

Fmoc-orn(mtt)-oh

C40H38N2O4 (610.2831428000001)

[(1R,2S,3R,4S,4aR,5S,6R,8S,8aR)-5-[(3aR,5S,6aS)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-5-yl]-3,8-diacetyloxy-8a-(acetyloxymethyl)-4-hydroxy-5,6-dimethylspiro[3,4,4a,6,7,8-hexahydro-2H-naphthalene-1,2-oxirane]-2-yl] 2-methylbutanoate

C31H46O12 (610.2989116)

Arg-Trp-Ser-Tyr

C29H38N8O7 (610.2863318)

A tetrapeptide composed of L-arginine, L-tryptophan, L-serine, and L-tyrosine joined in sequence by peptide linkages.

DGGA 22:5;O

C31H46O12 (610.2989116)

PA 20:4/8:3;O2

C31H47O10P (610.2906691999999)

PA 20:5/8:2;O2

C31H47O10P (610.2906691999999)

PA 28:7;O2

C31H47O10P (610.2906691999999)

ST 25:3;O6;GlcA

C31H46O12 (610.2989116)

ST 25:4;O7;Hex

C31H46O12 (610.2989116)

(1r,2s,3r,4s,4ar,5s,6r,8s,8ar)-5-[(2s,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-3,8-bis(acetyloxy)-8a-[(acetyloxy)methyl]-4-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl (2s)-2-methylbutanoate

C31H46O12 (610.2989116)

atractyloside a 14-o-β-d-fructofuranoside

C27H46O15 (610.2836566)

{"Ingredient_id": "HBIN017301","Ingredient_name": "atractyloside a 14-o-\u03b2-d-fructofuranoside","Alias": "NA","Ingredient_formula": "C27H46O15","Ingredient_Smile": "CC1(C2CC(CCC(C2CC1=O)(COC3(C(C(C(O3)CO)O)O)CO)O)C(C)(C)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14418","TCMID_id": "1974","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

blepharocalyxin c

C38H42O7 (610.2930382)

{"Ingredient_id": "HBIN018649","Ingredient_name": "blepharocalyxin c","Alias": "NA","Ingredient_formula": "C38H42O7","Ingredient_Smile": "C1C(OC(C(C1O)C(CC(CCC2=CC=C(C=C2)O)O)C=CC3=CC=C(C=C3)O)C4=CC=C(C=C4)O)CCC5=CC=C(C=C5)O","Ingredient_weight": "610.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2498","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101065840","DrugBank_id": "NA"}

(1r,2s,3r,4s,4ar,5s,6r,8s,8ar)-5-[(3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-3,8-bis(acetyloxy)-8a-[(acetyloxy)methyl]-4-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylbutanoate

C31H46O12 (610.2989116)

(2s,3s,4s,6s)-3-[(1e,3s,5s)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-yl]-2-(4-hydroxyphenyl)-6-[2-(4-hydroxyphenyl)ethyl]oxan-4-ol

C38H42O7 (610.2930382)

3-[5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-yl]-2-(4-hydroxyphenyl)-6-[2-(4-hydroxyphenyl)ethyl]oxan-4-ol

C38H42O7 (610.2930382)

(1s,3as,4r,7r,8ar)-4-({[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}methyl)-1,4-dihydroxy-1-methyl-7-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-hexahydro-3h-azulen-2-one

C27H46O15 (610.2836566)

4-({[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}methyl)-1,4-dihydroxy-1-methyl-7-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-hexahydro-3h-azulen-2-one

C27H46O15 (610.2836566)

(1r,4s,7s,9s,10s,13r,15s)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]oxan-2-yl]oxy}-15-hydroxy-9-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,5-dicarboxylic acid

C31H46O12 (610.2989116)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl (1s,4as,8ar)-5-[2-(furan-3-yl)ethyl]-1,4a,6-trimethyl-2,3,4,7,8,8a-hexahydronaphthalene-1-carboxylate

C31H46O12 (610.2989116)

(2s,3s,4s,6s)-3-[(1e,3r,5s)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-yl]-2-(4-hydroxyphenyl)-6-[2-(4-hydroxyphenyl)ethyl]oxan-4-ol

C38H42O7 (610.2930382)

n-{3-[(2s,5s,8s,14s)-5-benzyl-3,6,9,12,15-pentahydroxy-8-(hydroxymethyl)-14-[(4-hydroxyphenyl)methyl]-1,4,7,10,13-pentaazacyclopentadeca-1(15),3,6,9,12-pentaen-2-yl]propyl}guanidine

C29H38N8O7 (610.2863318)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-1,3-dihydroxypropylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C29H38N8O7 (610.2863318)

n-{3-[5-benzyl-3,6,9,12,15-pentahydroxy-8-(hydroxymethyl)-14-[(4-hydroxyphenyl)methyl]-1,4,7,10,13-pentaazacyclopentadeca-1(15),3,6,9,12-pentaen-2-yl]propyl}guanidine

C29H38N8O7 (610.2863318)

7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]oxan-2-yl]oxy}-15-hydroxy-9-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,5-dicarboxylic acid

C31H46O12 (610.2989116)

(2r,3r,4s,6s)-3-[(1e,3s,5s)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-yl]-2-(4-hydroxyphenyl)-6-[2-(4-hydroxyphenyl)ethyl]oxan-4-ol

C38H42O7 (610.2930382)